“Clinical Trials in Crisis”
November 7 - 8, 2006. Baltimore, Maryland

Summit Series on Cancer Clinical Trials X, entitled “Clinical Trials in Crisis,” focused on critical issues facing those involved in clinical research due to a changing research environment, including regulatory changes and reductions in federal funding.
View Summit X Executive Summary (Word)

Tuesday, November 7

Session One: Crisis In Clinical Trials
Session Two: Challenges In Clinical Trials Design For The Future: Improving Access Without Compromising Scientific Integrity

Wednesday, November 8

Session Three: Work Group Reports
Session Four: Summit Series Strategic Plan

View All Summit X Speaker Bios

Session One: Crisis in Clinical Trials

Moderator:
Virginia Bianco-Mathis, PhD
Marymount University and Strategic Performance Group

• Overview
  Al B. Benson, III, MD, FACP; Northwestern University School of Medicine
  
  
• Community
  James L. Wade, III, MD, FACP; Cancer Care Institute, Decatur Memorial Hospital
  
  
• Academia
  Al B. Benson, III, MD, FACP; Northwestern University School of Medicine
  
  
• Nursing
  Debra Barton, RN, PhD, AOCN; Mayo Clinic College of Medicine
  
  
• Patients: Trial Design
  Jane Perlmutter, PhD, Y-ME National Breast Cancer Organization; Gemini Group
  
  
• Patients: The Clinical Trial System
  Mike Katz, MD; International Myeloma Foundation and Eastern Cooperative Oncology Group
  
  
• Minorities and Racial Disparities
  Armin D. Weinberg, PhD; Baylor College of Medicine

Session Two: Challenges In Clinical Trials Design For The Future: Improving Access Without Compromising Scientific Integrity

Moderator: Susan Dentzer, The NewsHour with Jim Lehrer on PBS

• Pharmaceutical Research and Manufacturers of America (PhRMA)
  Caroline J. Loew, PhD
  
  
• National Cancer Institute
  Sheila A. Prindiville, MD, MPH
  
  
• US Food and Drug Administration
  Samir N. Khleif, MD
  
  
• Centers for Medicare and Medicaid Services
  Tamara Syrek Jensen, PhD
  

Session Three: Work Group Reports

• WG 1/3: Patient Education & Communication
  Heidi E. Ehrenberger, RN, PhD, AOCN, University of Maryland School of Nursing
  Dale L. Mintz, MPA, CHES, HADASSAH
  Merel Grey Nissenberg, Esquire, National Alliance of State Prostate Cancer Coalitions and the California Prostate Cancer Coalition
  
  
• WG 2: Health Care Provider Resources for Successful Clinical Trials Participation
  Linda U. Krebs, RN, PhD, AOCN, University of Colorado School of Nursing
  Elda Railey, Research Advocacy Network
  
  
• WG 4/5: Adequate Reimbursement of Research Costs
  Al B. Benson, III, MD, FACP; Northwestern University School of Medicine
  
  
• WG 6: Moving from Informed Consent to Informed Choice
  Robert B. Catalano, PharmD, Coalition of Cancer Cooperative Groups
  Peggy Devine, BS, CLS, Cancer Information & Support Network, Inc.

Session Four: Summit Series Strategic Plan

• Strategic Plan Overview
  Facilitator: Virginia Bianco-Mathis, PhD